Alprazolam API Manufacturers
compare suppliers & get competitive offers
To view suppliers for this material, you need to be logged in first.
This is because of international laws regarding narcotic materials. Furthermore, the contents of this page are only accessible if you are professionaly active in the pharmaceutical industry. In case you are, it is possible to register on our platform, and after your account is approved by our team you will be able to view suppliers and send your request.
Looking for Alprazolam API 28981-97-7?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Alprazolam. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Alprazolam
- Synonyms:
- Alprazolam , Xanax
- Cas Number:
- 28981-97-7
- DrugBank number:
- DB00404
- Unique Ingredient Identifier:
- YU55MQ3IZY
About Alprazolam
So, what does it do? Alprazolam is a triazolobenzodiazepine indicated for the treatment of anxiety and panic disorders. It is mainly metabolized by CYP3As and so is contraindicated with CYP3A inhibitors like ketoconazole and itraconazole. Benzodiazepine treatment should be stopped gradually by tapering down a patient's dose to avoid withdrawal symptoms. Alprazolam's adverse effects are generally related to the sedation it can cause. Alprazolam has been mixed with alcohol as a drug of abuse to potentiate the sedative effects of the drug which may lead to coma and death. Alprazolam was given FDA approval on October 19817.
More information such as the structure, indication or toxicity is available on Drugbank, click the ID above.
Alprazolam is a type of Benzodiazepine agonists
Benzodiazepine agonists are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that possess specific pharmacological properties similar to benzodiazepine drugs. These compounds are widely used in the medical field for their anxiolytic (anti-anxiety), sedative, hypnotic, muscle relaxant, and anticonvulsant effects. Benzodiazepine agonists work by binding to specific receptors in the central nervous system (CNS), known as benzodiazepine receptors. This interaction enhances the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits neuronal activity, leading to a calming effect on the CNS.
These APIs find applications in various medical conditions, including anxiety disorders, insomnia, seizures, muscle spasms, and alcohol withdrawal symptoms. Some commonly prescribed benzodiazepine agonists include diazepam, lorazepam, alprazolam, and clonazepam.
Due to their widespread usage, benzodiazepine agonists undergo rigorous quality control and testing to ensure purity, potency, and safety. They are manufactured under strict pharmaceutical guidelines and regulations to meet the standards set by regulatory authorities.
It's important to note that benzodiazepine agonists should be used with caution due to the potential for dependence and abuse. They are typically prescribed for short-term use to minimize these risks.
In summary, benzodiazepine agonists are a class of pharmaceutical APIs that mimic the effects of benzodiazepine drugs, providing therapeutic benefits for anxiety, insomnia, seizures, and muscle spasms. They are crucial tools in medical treatment but require careful monitoring and responsible use to mitigate potential risks.
Alprazolam (Benzodiazepine agonists), classified under Anti-anxiety
The Anti-anxiety category in the pharmaceutical API (Active Pharmaceutical Ingredient) market refers to a group of substances specifically developed to alleviate symptoms associated with anxiety disorders. Anxiety disorders are mental health conditions characterized by excessive worry, fear, and unease that can significantly impact daily life.
Pharmaceutical APIs within the Anti-anxiety category work by modulating the activity of neurotransmitters in the brain, particularly gamma-aminobutyric acid (GABA). GABA is an inhibitory neurotransmitter that helps regulate the excitability of neurons. By enhancing GABA's inhibitory effects, these APIs promote a calming effect, reducing anxiety symptoms.
Common Anti-anxiety APIs include benzodiazepines, such as alprazolam, diazepam, and lorazepam. These substances act as central nervous system depressants, inducing sedation and relaxation. Other APIs in this category include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and certain antihistamines.
Pharmaceutical companies develop and manufacture Anti-anxiety APIs to meet the growing demand for effective anxiety treatment options. These APIs are typically used as the active ingredient in the production of various anti-anxiety medications, such as tablets, capsules, or liquid formulations.
The market for Anti-anxiety APIs is influenced by factors such as increasing awareness about mental health, rising prevalence of anxiety disorders, and the growing demand for personalized treatment options. Regulatory compliance, quality control, and safety are crucial considerations in the development and production of these APIs to ensure efficacy and minimize potential side effects.
Overall, Anti-anxiety APIs play a vital role in the pharmaceutical industry by providing effective solutions for individuals struggling with anxiety disorders, enhancing their quality of life, and promoting overall well-being.
